-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Watson Biotech (300142.SZ) announced that the freeze-dried herpes zoster virus mRNA vaccine jointly developed by the company's subsidiaries Beijing Watson Innovation Biotechnology Co., Ltd., Yunnan Vaccine Laboratory Co., Ltd., Yuxi Watson Biotechnology Co., Ltd. and Fudan University and Shanghai Blue Magpie Biomedical Co., Ltd. (“Blue Magpie Biology”) has completed preparations for phase I clinical trials. A phase I clinical trial launch meeting was held today to officially launch phase I clinical trials.

Zhitongcaijing·10/14/2026 12:41:38
Listen to the news
Zhitong Finance App News, Watson Biotech (300142.SZ) announced that the freeze-dried herpes zoster virus mRNA vaccine jointly developed by the company's subsidiaries Beijing Watson Innovation Biotechnology Co., Ltd., Yunnan Vaccine Laboratory Co., Ltd., Yuxi Watson Biotechnology Co., Ltd. and Fudan University and Shanghai Blue Magpie Biomedical Co., Ltd. (“Blue Magpie Biology”) has completed preparations for phase I clinical trials. A phase I clinical trial launch meeting was held today to officially launch phase I clinical trials.